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Introduction
A recurring theme in Parkinson’s disease research is the 
possibility that exposure to an environmental contami-
nant or chemical can accelerate or even cause Parkinson’s 
disease (PD) (Horowitz and Greenamyre 2010). Much of 
this evidence is based on findings derived from exposure 
to MPTP, a contaminant of synthetic meperidine used by 
drug abusers, which can cause acute onset Parkinsonism in 
man and animals (Langston et al. 1983). MPTP is known 
to undergo reduction to the neurotoxic metabolite MPP+ 
via monoamine oxidase and then to selectively enter dopa-
minergic neurones by dopamine transporter-mediated 
uptake (Javitch et al. 1985). Within dopaminergic neu-
rones, MPP+ inhibits complex I (CI) of the mitochondrial 
respiratory chain causing excessive formation of superox-
ide and other free radicals (Ramsay et al. 1986). Evidence 
from some studies has linked mitochondrial dysfunction 
with the development of Parkinson’s disease (Keane et al. 
2011). Discovery of a mild deficiency in CI activity in the 
substantia nigra of PD patients (Schapira et al. 1989; Mann 
et al. 1994) followed by similar deficiencies in the frontal 
cortex (Parker et al. 2008), platelets (Blandini et al. 1998), 
lymphocytes (Barroso et al. 1993) and to a lesser extent in 
muscle tissue (Penn et al. 1995) showed that impairment 
of mitochondrial respiratory chain may be related to PD 
pathology since substantia nigra dopaminergic neurons 
appear more vulnerable to impairments of mitochondrial 
CI activity (Bender et al. 2006), and CI activity in the PD 
substantia nigra can be reduced by up to 30–40 % (Daw-
son and Dawson 2003). Mitochondria are central to the 
Abstract Evidence indicates that Parkinson’s disease 
(PD), in addition to having a genetic aetiology, has an envi-
ronmental component that contributes to disease onset and 
progression. The exact nature of any environmental agent 
contributing to PD is unknown in most cases. Given its 
similarity to paraquat, an agrochemical removed from reg-
istration in the EU for its suspected potential to cause PD, 
we have investigated the in vitro capacity of the related her-
bicide Diquat to cause PD-like cell death. Diquat showed 
greater toxicity towards SH-SY5Y neuroblastoma cells 
and human midbrain neural cells than paraquat and also 
MPTP, which was independent of dopamine transporter-
mediated uptake. Diquat caused cell death independently of 
caspase activation, potentially via RIP1 kinase, with only 
a minor contribution from apoptosis, which was accompa-
nied by enhanced reactive oxygen species production in the 
absence of major inhibition of complex I of the mitochon-
drial respiratory chain. No changes in α-synuclein expres-
sion were observed following 24-h or 4-week exposure. 
Diquat may, therefore, kill neural tissue by programmed 
necrosis rather than apoptosis, reflecting the pathological 
changes seen following high-level exposure, although its 
ability to promote PD is unclear.
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actions of several neurotoxins and selective CI inhibitors 
like MPP+, the pesticide rotenone and potentially the her-
bicide paraquat, which show features similar to PD when 
administered to both man and animals (Betarbet et al. 2006; 
Schmidt and Alam 2006).
The identification of environmental chemicals and con-
taminants capable of causing mitochondrial CI inhibition 
and/or of reproducing the pathology and biochemistry of 
PD would be of major benefit in reducing exposure and 
potentially reducing PD incidence. The herbicide diquat, 
which is structurally similar to paraquat, has replaced para-
quat where its use has been prohibited due to a suggested 
association with Parkinson’s disease (McCormack et al. 
2002) and is now in widespread use as an agricultural and 
home use herbicide. Diquat is known to be toxic acutely 
in high doses (Hantson et al. 2000; Jones and Vale 2000; 
Jovic-Stosic et al. 2009; Saeed et al. 2001; Schmidt et al. 
1999) and evidence of Parkinsonism after use of diquat has 
been suggested (Sechi et al. 1992). Acutely, diquat causes 
intracerebral haemorrhage particularly in the white matter 
but also in the brainstem with a necrotic appearance (Van-
holder et al. 1981). The toxic mode of action of diquat is 
thought to involve free radical generation although it is not 
clear how it achieves this; however, mitochondrial inhibi-
tion is suggested (Drechsel and Patel 2009). Given the rela-
tive lack of information on diquat, and its ability to influ-
ence mitochondrial inhibition and cell death, the effects of 
diquat at the cellular level, mode of action, involvement 
of cell signalling and cell death pathways (i.e. apoptosis, 
necrosis) were investigated to determine whether diquat 
can recapitulate some of the changes observed in PD.
Materials and methods
Cell culture
Analytical grade diquat was obtained from Sigma (Sigma 
45422). The SH-SY5Y neuroblastoma cell line was pur-
chased from the European Collection of Cell Cultures 
(Salisbury, UK). Cells were cultured in Dulbecco’s modi-
fied Eagle’s medium (DMEM) containing 10 % v/v heat-
inactivated foetal bovine serum (FBS), glutamine/penicil-
lin/streptomycin solution and 1 % v/v non-essential amino 
acids (all Sigma, Poole, UK). Cells were sub-cultured 
when growth reached 80–90 % confluence using trypsin–
EDTA solution using a 1:3 split ratio. Cells were incubated 
at 37 °C in a humidified atmosphere of 95 % air/5 % CO2.
For differentiation, SH-SY5Y cells were plated out at 
the required density in growth medium. Typical cell densi-
ties used were as follows: 10–20,000 cells/well in 6-well 
plates for experiments lasting 2 weeks; 100,000 cells/
well in 6-well plates for 1-week-long experiments and 
50,000–100,000 cells per 25-cm2 flask. Cells were incu-
bated overnight to allow recovery, and growth media was 
replaced with an equal volume of DMEM supplemented 
with 1 % FCS, 1 % l-glutamine, 1 % penicillin/strepto-
mycin solution, 1 % sodium pyruvate, 1 % non-essential 
amino acids, 0.3 mM dibutyryl cyclic AMP (dbcAMP) and 
10 mM retinoic acid (RA).
Cell viability and cytotoxicity assessment
For toxicity screening, SH-SY5Y cells were seeded at 
100,000 cells per well in 24-well plates. Following over-
night recovery, cells were exposed to chemicals overnight 
and cells tested for viability with 0.5 % Trypan blue and 
cells manually counted using a haemocytometer. Addition-
ally, Alamar Blue (0.001 % resazurin (Sigma) in Dulbec-
co’s phosphate-buffered saline) was added at 10 % of total 
growth medium volume (O’Brien et al. 2000). Plates were 
incubated at 37 °C and 5 % CO2 for 4 h after which tripli-
cates were taken from each well and Alamar Blue reduction 
measured at emission wavelength of 530 nm and excitation 
wavelength of 590 nm (O’Brien et al. 2000).
To assess the effects of potential inhibitors of cell toxic-
ity and to identify the mode of cell death, SH-SY5Y cells 
were exposed to diquat to give 40–60 % reduction in cell 
viability after overnight exposure. Cells were pre-incu-
bated for 3 h before toxin exposure with either necrosta-
tin-1 (Biomol), zVAD.fmk (Biomol), DEVD-CHO (Bio-
mol), Ac-LEVD-CHO (Biomol), N-acetyl-l-cysteine, NAC 
(Sigma), cyclosporin A (Sigma), 3-methyladenine (Sigma), 
ammonium chloride (Sigma), tiron (Sigma), or GW5074 
(Biomol). Following exposure, viability was determined 
using Alamar Blue reduction.
Human neural midbrain cultures
Human neural precursor stem cell (hNPSC) line N1997 
cells were grown as neurospheres according to previously 
described methods (Kurzawa-Akanbi et al. 2012; Burn-
stein et al. 2004) with National Research Ethics System 
approval in proliferation medium of DMEM/F12 (Sigma) 
supplemented with N-1 (1:100; Sigma N6530), B27 
(1:100; Invitrogen), epidermal growth factor (EGF; 20 ng/
ml; R& D Systems), basic fibroblast growth factor (FGF2; 
20 ng/ml; R&D Systems) and leukaemia inhibitory factor 
(LIF; 10 ng/ml; Sigma). Cells were incubated at 37 °C in 
a 5 % CO2, humidified incubator. Proliferation medium 
was replenished at 3–4-day intervals by replacing 60–70 % 
of the medium with fresh medium. For assay, cells were 
plated at 100,000 cells onto 2-well chamber slides (BD 
Falcon, BD Biosciences) or at 2,500 cells/ml in 8-well 
chamber slides (BD Falcon) coated with 0.5 % gelatine 
and grown for 10 days, at which point neurospheres had 
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attached. Growth medium was replaced with differentiating 
medium containing DMEM/F12 supplemented with 10 % 
heat-activated FBS (Sigma), N-1, B27, N-2, brain-derived 
neurotrophic factor (BDNF; 10 ng/ml; R&D Systems), 
glial-derived neurotrophic factor (GDNF; 10 ng/ml; R&D 
Systems), interleukin-1α (IL-1α; 100 pg/ml; R&D Sys-
tems), interleukin-11 (IL-11; 1 ng/ml; R&D Systems) and 
LIF. Conversion of neurospheres into cells with neuronal 
morphology took 2–3 days. Cells were allowed to grow 
for 14 days after which cytotoxicity testing was undertaken 
when cells were exposed to given concentrations of chemi-
cal for 24 h. Cytotoxicity was measured using Alamar Blue 
reduction assay, and cells stained for cellular antigens using 
standard immunofluorescence.
Twenty-four-hour and four-week toxin exposure
SH-SY5Y cells were plated out at the required density 
as described, and cells were exposed to selected toxins 
(diquat, MPP+, rotenone for 24 h and up to 4 weeks). Cell 
lysates were prepared using native lysis buffer (50 mM 
TRIS pH 7.4 (HCl), 0.27 M Sucrose, 1 % Triton X-100, 
1 × protease/phosphatase inhibitor cocktail (Roche)). Pro-
tein concentration was determined by Coomassie Plus Pro-
tein Assay Kit (Pierce, Rockford, IL) or Bradford assay 
(Pierce, Rockford, IL).
Western blotting
Equal amounts of protein (20 µg) were subjected to elec-
trophoresis through 12 % Bis–Tris gels (Invitrogen), and 
the separated proteins were transferred onto nitrocellulose 
membranes (Amersham Biosciences). Membranes were 
blocked for 1 h with 5 % non-fat dry milk in 1x TBS–
Tween 20 (0.05 % v/v), TBS-T, and then probed over-
night at 4 °C with selected antibodies (see Table 1). Mem-
branes were washed with TBS-T for 10 min, followed by 
incubation with HRP-conjugated secondary antibodies 
(AbCam) for 1 h. Membranes were washed with TBS-T, 
and ECL (GE Healthcare) was used for protein band detec-
tion through a G:BOX Chemi XL camera (SYNGENE). 
ImageJ version 1.38x (NIH, USA) was used to quantify 
each protein band of interest and results expressed against 
GAPDH band intensities.
Immunofluorescence
Cells were seeded onto 2-well or 8-well chamber slides 
(BD Falcon, BD Biosciences) and incubated with differ-
ent toxin doses for required period of time after which 
cells were fixed with 4 % paraformaldehyde (Sigma) for 
10 min and washed with PBS and permeabilised with PBS 
containing 0.1 % Triton X-100 (Sigma) for 10 min. Cells 
were blocked in 1 % bovine serum albumin (BSA; Sigma, 
UK) or 10 % goat serum and incubated overnight with pri-
mary antibodies at 4 °C. Cells were then washed with PBS 
and treated with Image-iT™ FX signal enhancer (Invitro-
gen), washed with PBS and then incubated with secondary 
antibodies (conjugated with Alexa Fluor® 488 or 594) for 
60 min. Slides were washed, nuclei stained with DAPI and 
then viewed under Zeiss Axioplan microscope (Carl Zeiss 
Ltd).
Determination of reactive oxygen species generation
To measure cellular reactive oxygen species (ROS), SH-
SY5Y cells were loaded with H2DCFDA molecular probe 
(10 µM, Invitrogen) and treated with hydrogen peroxide 
(0.5 mM), diquat, paraquat, rotenone or MPP+ (dose range 
0.001–1 mM) for 24 h. After this, triplicate media samples 
were taken from each well and fluorescence measured at 
emission wavelength of 485 nm and excitation wavelength 
of 520 nm. Alternatively, after toxin treatment, SH-SY5Y 
cells were extracted in a buffer containing 0.1 M Tris pH 
Table 1  Primary antibodies used in cellular analysis
Antibody Details Dilution
Cleaved caspase-3 Rabbit monoclonal, Asp175, Cell Signalling 1:1,000
Cleaved PARP-1 Human specific, Asp 214, Cell Signalling 1:1,000
Dopamine β-hydroxylase Rabbit polyclonal, DZ1020, Biomol 1:1,000
GAD67 Rabbit polyclonal, ab52249, Abcam 1:1,000
LC3B Rabbit polyclonal, L7543, Sigma 1:1,500
α-Synuclein Mouse IgG1, 610789, BD Biosciences 1:1,000
Phospho α-synuclein Mouse monoclonal, sc-12767, Santa Cruz 1:1,000
Phospho p53 serine 15 Rabbit polyclonal, 9284, Cell Signalling 1:1,000
Poly-ubiquitin Mouse monoclonal (clone FK1), PW8805, Biomol 1:1,500
RIP1 Rabbit IgG, 3493, Cell Signalling 1:1,000
Tyrosine hydroxylase Purified mouse monoclonal IgG1. Clone TH-2, mAb1423, R&D Systems 1:1,000
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7.4, 1 % triton X-100, and cell lysate fluorescence was 
measured at 485 nm emission/520 nm excitation.
Transfection of DJ-1 plasmid DNA
Five hundred nanograms of plasmid DNA (pCDNA 3.1/
Myc tagged DJ-1; Dr MR Cookson, NIH) was diluted in 
“Otpi-MEM® I Reduced Serum Medium” (Invitrogen) and 
lipofectamine reagent LTX (Invitrogen) and was added to 
each tissue culture well and incubated at 37 °C for 48 h 
after which cells were extracted in native lysis buffer and 
transfection efficiency measured by Western blotting. For 
toxin treatment, transfected cells 48 h following transfec-
tion were incubated with toxin for 24 h after which cell 
viability was measured using Alamar Blue reduction assay.
Mitochondrial complex assay
SH-SY5Y cells were grown to 80–90 % confluence and 
removed by scraping and the pellet suspended in 1–2 ml 
of ice-cold medium A (250 mM sucrose, 2 mM HEPES, 
0.1 mM EGTA, pH 7.4), and cells disrupted by 20 passes 
in a homogeniser with a tight-fitting, power-driven Tef-
lon plunger and homogenates centrifuged (600×g for 
10 min) at 4 °C. Mitochondria-rich supernatant was col-
lected, and the pellet containing the cell debris resus-
pended in 800 μl medium A and homogenised and cen-
trifuged as before. The two supernatants were pooled and 
centrifuged (11,000×g for 10 min) at 4 °C. The resultant 
mitochondrial fraction was suspended in 400 µl medium 
A and stored in aliquots at −80 °C. All respiratory chain 
complex assays were performed in a final volume of 
0.1 ml using a Cary WinUV spectrophotometer. Pig heart 
mitochondrial fractions were used as internal control to 
check normal function of the assays. Assay of mitochon-
drial complex I and complex II activity was determined 
using standard methods (Kirby et al. 2007) using citrate 
synthase activity as an internal control of mitochondrial 
mass.
Analysis of mitochondrial membrane potential
Changes in mitochondrial membrane potential (ΔΨm) were 
estimated using tetramethylrhodamine ethyl ester (TMRE; 
Molecular Probes) (Krohn et al. 1999). For estimation of 
ΔΨm, cells were incubated with 250 nM TMRE for 45 min 
at 37 °C and fluorescence at excitation 549 nm and emis-
sion 574 nm determined. The protonophore carbonyl cya-
nide p-trifluoromethoxy-phenylhydrazone (FCCP; 0.1 μM, 
Sigma) was used as a positive control and added 15 min 
prior to the end of the treatment (Gunter and Pfeiffer 1990). 
The fluorescence for each treatment was expressed as per 
cent fluorescence change compared with control.
Cellular distribution of mitochondria
SH-SY5Y cells were seeded onto 2-well or 8-well cham-
ber slides, allowed to recover overnight before loading 
with MitoTracker® Red CMXRos (1 µM Invitrogen) for 
30 min. Growth media was replaced and toxins added at the 
required concentrations and incubated for 24 h after which 
cells were fixed with 1 % paraformaldehyde in phosphate-
buffered saline and viewed using a fluorescent microscope.
Statistical analysis
Results are expressed as the mean ± SD of at least three 
independent experiments. The statistical significance 
was determined using ANOVA with unpaired t test with 
P < 0.05 considered statistically significant.
Results
Effect of toxin treatment on cell viability and cytotoxicity
SH-SY5Y cells were treated with different toxin concen-
trations (0.001 to 1 mM) overnight. Diquat application 
caused significant cell death in the range 50 µM–1 mM 
following overnight exposure, substantially greater than 
paraquat (0.5–1 mM; data not shown) and MPTP or 
MPP+ (1–2 mM) and slightly less toxic than rotenone 
(10 µM–1 mM) (see Fig. 1). Similar results were seen with 
human midbrain dopaminergic neurones (Table 2). After 
14 days, differentiated cells showed that chemicals reduced 
cell viability in a dose-dependent manner with diquat 
causing significant cytotoxicity at 100 µM and 10 µM, 
and rotenone causing significant reductions in viability at 
100 µM, 10 µM and 1 µM, whereas MPTP and MPP+ were 
only moderately toxic at 100 µM. Differentiation of mid-
brain-derived hNPCs produced approximately 70 % Tuj-1 
expressing neurones and 30 % expressing the astrocyte 
marker GFAP (not shown) and on average 30.3 ± 10.7 % 
TH-positive neurones. In addition to the presence of TH-
positive neurones, markers for GABA and glutamatergic 
neurones were also present indicating a mixed neuronal 
population derived from midbrain hNPC. Average percent-
age viability of hNPCs and SH-SY5Y cells was compared, 
and results showed that hNPCs were marginally more sen-
sitive to these toxins, especially at 100 µM (see Table 2). 
Co-staining and subsequent cell counts of TH and Tuj1 
positive cells showed that these toxins did not specifically 
target TH-positive neurones as no significant difference in 
the number of either marker was observed (not shown).
To determine whether the cytotoxicity of diquat required 
mediation by dopamine transporter (DAT) and there-
fore acts selectively as with MPTP/MPP+, SH-SY5Y 
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Fig. 1  Effects of toxin 
treatment on SH-SYSY cell 
viability. Cells were incubated 
overnight with a range of toxin 
concentrations and cell viability 
determined using Alamar Blue 
reduction. a Diquat, b MPP+, 
c rotenone and d paraquat. 
Hydrogen peroxide (0.5 M) 
was used as a positive control. 
*P < 0.05, **P < 0.01, unpaired 
t test
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cells were co-incubated with specific dopamine trans-
porter inhibitors GBR12909 and 1-[1-(2-Benzo[b]thienyl)
cyclohexyl)]piperidine hydrochloride (BTCP hydrochlo-
ride) for 2 h before diquat was added. It has been sug-
gested that differentiated cells show greater sensitivity than 
undifferentiated cells because DAT is highly expressed in 
differentiated cells. Therefore, both undifferentiated and 
differentiated SH-SY5Y cells were used. Western blotting 
analysis showed that the SH-SY5Y cell line expressed DAT 
normally and there was no significant difference in protein 
levels after 5-day differentiation (Fig. 2a). Cell viability 
measured after overnight exposure showed that these inhib-
itors did not protect cells against cytotoxicity or affect the 
degree of cell death in undifferentiated (Fig. 2b) or differ-
entiated cells (not shown). Different concentrations of DAT 
inhibitors were used, and all of these failed to show any 
reduction in cytotoxicity of diquat (not shown).
Effect of cell death inhibitors on cytotoxicity
SH-SY5Y cells were treated with toxins or vehicle 
(DMSO) in the presence or absence of specific caspase-3/9 
inhibitors or z-VAD-fmk, a cell-permeable broad-spec-
trum caspase inhibitor (Amstad et al. 2001). Z-VAD-fmk 
treatment showed a slight reduction in toxicity of diquat 
(0.1 mM), although this was not statistically significant 
(Fig. 3). Similarly, treatment with the specific caspase-3 
inhibitor (DEVD-CHO) and caspase-9 inhibitor (Ac-
LEVD-CHO) also failed to affect toxicity (Fig. 3).
To identify alternative cell death pathways involved in 
diquat toxicity, necrostatin-1 (Nec-1) (Degterev et al. 2005) 
and 3-methyl adenine (3-MA) were used. Pre-treatment with 
the macroautophagy inhibitor 3-MA (1.5, 5 and 25) failed to 
prevent cell death associated with diquat (not shown) as did 
use of siRNA-mediated knockdown of the autophagy-related 
protein ATG5 (not shown). Nec-1 (100 µM), however, 
showed significant increase in viability when SH-SY5Y 
cells were treated with diquat (100 µM) (Fig. 4) and also 
with 1 mM MPP+ and 1 µM rotenone (not shown). Calcula-
tion of average increase in cell viability showed that Nec-1 
caused 74.2 % recovery in diquat (100 µM)-treated cells. 
Whilst in control cells Nec-1 appears to increase Alamar 
Blue fluorescence, Nec-1 did not alter cell numbers (not 
shown). Since use of Nec-1 caused a significant reduction 
in cell death and over-expression of RIP1 can induce both 
NF-κB activation and apoptosis (Hsu et al. 1996), we there-
fore determined whether Nec-1 affects RIP1 protein expres-
sion, the primary target of Nec-1 (Degterev et al. 2008). 
Results showed no change in the endogenous levels of total 
and cleaved RIP1 protein after toxin treatment and RIP 
Table 2  Percentage viability 
comparison between SH-SY5Y 
cells and hNPCs after 24-h 
toxin exposure
Percentage of vehicle-treated 
control
Toxin Concentration (mM)
SH-SY5Y cells Human midbrain cells
0.1 0.01 0.001 0.1 0.01 0.001
Rotenone 60 100 100 50 70 80
MPP+ 80 95 100 50 80 80
MPTP 95 100 100 50 100 100
Diquat 45 100 100 45 75 100
(a)
(b)
Undifferentiated Differentiated
DAT
GAPDH
TH
DβH
Fig. 2  a Western blot analyses of DAT in undifferentiated and dif-
ferentiated SHSY5Y cells demonstrating the presence of dopa-
mine transporter (DAT), tyrosine hydroxylase (TH) and dopamine 
β-hydroxylase (DβH) expression in both undifferentiated and dif-
ferentiated cells after 5 days. b Effect of DAT inhibitors GBR 12909 
and BTCP on cytotoxicity: cells were exposed to the dopamine trans-
porter inhibitor GBR12909 for 2 h prior to exposure to diquat (DQ) 
with the continuous presence of DAT inhibitor. No significant reduc-
tion in toxicity was observed suggesting the DQ uptake into cells is 
not DAT mediated
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expression in control cells pre-incubated with Nec-1 failed to 
show any significant change in RIP levels (data not shown).
Changes in protein expression after diquat exposure
Using antibodies which selectively recognise the 89 kDa 
cleaved fragment, diquat treatment showed PARP-1 cleav-
age at 1, 10, 100 µM (Fig. 5a) but only after 12–24 h of 
high-level diquat exposure after which levels diminished 
(Fig. 5b). Western blots failed to detect diquat-associated 
changes of the large fragment (17/19 kDa) of activated cas-
pase-3, which results from cleavage adjacent to Asp175 
(data not shown).
To determine whether an autophagic mechanism other 
than macroautophagy may be involved in diquat toxicity, 
the autophagic marker protein LC3-IIb was determined fol-
lowing exposure. Treatment with different doses of diquat 
showed a significant increase in LC3-IIb expression at 
100 µM (Fig. 5). Results showed significant increase in 
protein levels after 24-h exposure followed by a decrease 
at 48 h complementing the data gathered from cytotoxicity 
screening suggesting maximum toxicity at 24 h after which 
cell number falls off due to high toxicity (Fig. 5a, b).
To determine whether α-synuclein, a key component 
of Lewy bodies in PD, may be involved in diquat toxic-
ity, α-synuclein protein expression levels (wild-type and 
α-synuclein phosphorylated at Ser129) were assessed after 
24-h treatment. Immunoblots showed a single 19 kDa 
wild-type band and additional heavy bands between 40 
and 55 kDa with anti-α-synuclein and anti-phosphorylated 
α-synuclein antibodies, respectively. Results showed treat-
ment with diquat had no effect on endogenous α-synuclein 
expression (data not shown). Similarly cells grown con-
tinuously in medium containing lower concentrations of 
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Fig. 3  Effect of caspase inhibition on cell viability. Cells were 
pre-incubated with zVAD.fmk (1 µM), DEVD-CHO (1 µM) or 
Ac-LEVD-CHO (1 µM) for 2 h before diquat addition. After 24-h 
incubation, cell viability was evaluated by Alamar Blue reduction 
assay. The data are expressed as mean ± SD (*P values <0.05 were 
accepted as significant). ns Not significant
*
0
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100
120
140
Untreated Nec-1 (0.1) DQ (0.1) Nec-1  + DQ
Fig. 4  Effects of necrostatin-1 on cell viability after diquat treatment. 
A cells were treated with 100 µM necrostatin-1 (Nec-1) for 2 h before 
addition of diquat (DQ) and continuously exposed to Nec-1 through-
out. A significant increase in viability was observed following treat-
ment (*P < 0.01)
Cleaved 
PARP
LC3
H2O2 Untreated         1µM              10µM           100µM        
H2O2 Untreated            2H           4H            6H                 24H           48H
Cleaved 
PARP
LC3
(a)
(b)
Fig. 5  Effect of diquat treatment on PARP-1 and LC3 expression. 
Expression of cleaved PARP-1 by Western blot analysis after a 24 h 
1, 10 and 100 µM diquat exposure and b 48-h treatment at 100 µM 
diquat exposure with protein cleavage only occurring at 24-h expo-
sure. Similar effects were seen with the expression of the autophagic 
marker protein LC3 – II6 (lower panel) after diquat exposure
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diquat (1 µM) for 4 weeks showed no significant change in 
α-synuclein levels (data not shown).
Measurement of reactive oxygen species (ROS) 
in toxin-treated cells
We used 2′,7′-dichlorofluorescin diacetate (DCFDA) to 
detect a number of ROS species, including H2O2, super-
oxide anions and hydroxyl radical since it is generally 
accepted that fluorescence is proportional to H2O2 concen-
tration (Gomes et al. 2005). Hydrogen peroxide (500 µM) 
used as a positive control caused a significant increase in 
fluorescence from 2 to 4 h (Fig. 6). After 24 h, cell viabil-
ity had reduced to less than 10 % of untreated control, 
which was reflected in significantly lower fluorescence (not 
shown). Diquat (1–500 μM) caused a significant increase 
in ROS production (Fig. 6). Paraquat did not cause sig-
nificant cell death at lower doses and showed similarly a 
Fig. 6  Toxin-induced ROS 
production in SH-SY5Y cells. 
A dose-dependent increase in 
ROS production was noted with 
diquat (a), paraquat (b), MPP+ 
(c) and rotenone (d) (results are 
mean ± SD, of at least three 
replicates. P values <0.05* 
or <0.01** were accepted as 
significant)
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low pattern of ROS generation (Fig. 6) in SH-SY5Y cells, 
which was also seen with MPP+ where 0.001, 0.01 and 0.5 
doses did not affect cell viability nor induced any changes 
in fluorescence (Fig. 6). Overnight incubation with differ-
ent doses of rotenone (0.001, 0.01 and 0.05 mM) showed 
significantly higher DCF fluorescence with a 0.1 mM 
dose causing significant cell death and very low levels of 
fluorescence.
Effect of antioxidants on diquat-induced SH-SY5Y cell 
death
Since ROS were produced after diquat exposure, antioxi-
dant molecules N-acetyl-L-cysteine (NAC), tiron, MnT-
BAP and MnTMPyP were tested for their ability to inhibit 
the death of SH-SY5Y cells following diquat exposure. Co-
incubation of NAC (5 mM) caused a significant recovery 
in diquat (100 µM)-treated cells (see Table 3). No NAC-
related recovery was evident in MPP+ (1 mM)-treated 
cells. Tiron (4,5-dihydroxy-1,3-benzene disulphonic acid) 
is an antioxidant metal chelator but failed to increase via-
bility with diquat (100 µM) or MPP+ (1 mM). Both MnT-
BAP and MnTMPyP act as antioxidant superoxide dis-
mutase mimetics, but co-incubation with these chemicals 
showed no significant increase in cell viability. Similarly, 
transfection with plasmid expressing the Parkinson’s dis-
ease associated with protein DJ-1 which is suggested to 
have anti-oxidant effects showed no rescue of cell viability 
following diquat exposure (not shown).
Measurement of mitochondrial transmembrane potential
Pathological conditions involving ATP depletion, oxidative 
stress and Ca2+ can disrupt mitochondrial transmembrane 
potential, ΔΨm (Skarka and Ostadal 2002). Measurement of 
ΔΨm at different time points using the potential sensitive dye 
TMRE showed that diquat caused significant loss of ΔΨm in 
a time-dependent manner (Fig. 7). Chemicals known to affect 
ΔΨm such as rotenone and MPP+ also caused a significant 
gradual reduction in TMRE fluorescence (see Fig. 7).
Twenty-four-hour toxin exposure effects on complex I 
and complex II activities
Given the cellular toxicity of diquat and its potential to 
act in a similar way to rotenone and MPP+, we sought to 
determine whether diquat affects the mitochondrial res-
piratory chain directly. Using isolated SH-SY5Y cell mito-
chondria, the activities of complex I and II in untreated SH-
SY5Y cells were determined. Rotenone (5 µM) was used 
to completely inhibit CI activity, which was measured as 
the rotenone-sensitive NADH: ubiquinone oxidoreductase 
activity. Comparison of treatment with and without rote-
none (Fig. 8) clearly showed that after 5 min when rotenone 
is added to the reaction mixture, the decrease in absorbance 
due to the oxidation of NADH is stopped, though CI activ-
ity showed no significant change when measured at a lower 
dose (25 nM) at different time points. Given the rapidity of 
how rotenone acts, different compounds were added to the 
reaction mixture and CI activity measured immediately to 
determine whether they are as potent as rotenone in inhib-
iting CI. Results showed that diquat, paraquat and MPP+ 
had no immediate inhibitory effect on CI activity (Fig. 8).
Since MPP+ has been suggested to inhibit CI activ-
ity (Ramsay et al. 1989), MPP+ was added to SH-SY5Y 
mitochondrial extracts at 10 nM and 100 nM doses and 
incubated for 1 h after which complex I or II activity was 
measured. Results showed a significant effect on CI activ-
ity at 100 nM, although the level of reduction was not as 
high as with rotenone (Fig. 9). Complex II activity was, 
however, unaffected after 1-h exposure. Within cells, 
diquat undergoes redox cycling producing superoxide ani-
ons (Sandy et al. 1986), but it is not known if diquat dam-
ages mitochondria through mitochondrial CI inhibition. 
Results showed that 1-h diquat treatment at 1 µM, 10 µM 
and 100 µM failed to significantly reduce mitochondrial 
CI activity (Fig. 9). The use of a very high dose (1 mM), 
however, showed a time-dependent and significant reduc-
tion of CI activity (not shown). Complex I activity at 30, 45 
and 60 min showed a percentage reduction of 17 % ± 0.93, 
52 % ± 0.93 and 64 % ± 1.11, respectively. Complex II 
activity was unaffected even after 1 h exposure. Paraquat 
also failed to inhibit CI activity even at 1 mM (not shown) 
suggesting that paraquat does not inhibit CI.
Chronic rotenone exposure has been linked with an 
increase of α-synuclein in SK-N-MC cells (Betarbet et al. 
2006), and sub-lethal doses of rotenone in Drosophila 
cause selective loss of dopaminergic neurons inducing 
motor deficits (Coulom and Birman 2004). In undifferen-
tiated SH-SY5Y cells treated with diquat (10 μM) for a 
period of 5 weeks, CI activity was higher than untreated 
cells (Table 4), whilst CII activity remained unaltered. 
No changes were seen with chronic 0.05 µM rotenone or 
10 μM MPP+ treatment.
Table 3  Effects of antioxidant molecules on cell death in response to 
diquat
Cells were pre-incubated with the chemical for 3 h prior to diquat or 
MPP+ treatment and then exposed to either 50uM diquat or 1 mM 
MPP+ overnight and toxicity determined with positive integers indi-
cating cell survival and negative integers representing enhanced cell 
death. Results are the mean of at least three independent replicates 
(*P < 0.05, post hoc paired t test)
Inhibitor Effect diquat MPP+
NAC Glutathione mimetic +24.6* ± 5.2 −25* ± 0.03
Tiron Free radical scavenger −14.4* ± 12.0 0.04 ± 0.01
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Toxin exposure and mitochondrial distribution
To investigate the effect of toxin exposure on mitochon-
drial distribution, SH-SY5Y cells were incubated with 
MitoTracker® Red CMXRos before overnight toxin treat-
ment including diquat (100 µM), MPP+ (500–1000 µM) 
and rotenone (50 µM) (Fig. 10). Results showed mito-
chondrial aggregation in treated cells compared with uni-
form distribution in untreated cells. In H2O2-treated cells, 
a marked reduction in overall staining was observed along 
with aggregates in a cytoplasmic location within the cell 
body. Similar results were observed in rotenone and MPP+ 
treated cells (Fig. 10). Aggregate formation in diquat-
treated cells was dose dependent with a relatively smaller 
number of aggregates seen with 1 µM dose, but their num-
ber increased when treated at 10 and 100 µM (Fig. 10).
Discussion
The suggestion that PD has an environmental compo-
nent involving a chemical exposure has been suggested 
although, with the exception of MPTP, specific chemicals 
have not been identified. To address this, we investigated 
the potential for diquat, a herbicide widely used in agricul-
ture and home horticulture. Exposure of SH-SY5Y cells 
and hNPC-derived neurones to diquat showed a greater 
dose-dependent reduction in viability compared to MPTP 
or MPP+, or to paraquat, which showed only modest toxic-
ity (>1 mM). MPP+ shows its selective toxicity to dopa-
minergic neurones through DAT-mediated uptake and DAT 
and DA receptors are expressed in SH-SY5Y cells (Pres-
graves et al. 2004) (Javitch et al. 1985). Inhibition of DAT 
does not, however, alleviate diquat toxicity suggesting an 
alternative transport mechanism lack of specificity for 
dopaminergic neurones, which was seen with NPC-derived 
midbrain cultures where diquat also killed GABA-ergic 
neurones. It is currently unclear which system diquat uses 
for cell entry, but indications are that diquat does not enter 
cells using the system L carrier (LAT-1), which transports 
paraquat into the brain (Shimizu et al. 2001). Whilst rote-
none toxicity is also independent of DAT, rotenone shows 
relatively selective dopaminergic toxicity despite wide-
spread mitochondrial CI inhibition (Betarbet et al. 2006), 
possibly due to selective vulnerability of dopaminergic 
neurons (Bender et al. 2006; Elstner et al. 2009). There-
fore, despite a potential lack of in vitro selectivity at the 
high doses used here to promote cytotoxicity, diquat may 
still be able to cause selective dopaminergic degeneration 
in vivo (Sechi et al. 1992). A major feature of the majority 
of forms of PD associated with degeneration of dopamin-
ergic neurones is the presence of deposits of α-synuclein 
protein as Lewy bodies and Lewy neurites. α-Synuclein 
Fig. 7  Effect of diquat on mitochondrial trans membrane potential 
(ΔΨm). Cells were loaded with the mitochondrial redox sensitive 
dye TMRE and at selected time points following exposure TMRE 
fluorescence determined as a percentage of untreated cells. Hydrogen 
peroxide (a) showed a rapid loss of TMRE fluorescence similar to 
the mitochondrial uncoupler FCCP (0.001 mM). Diquat (0.150 mM, 
b), MPP+ (1 mM, c) and rotenone (0.0125 mM, d) showed a slower, 
time-dependant but significant reduction in TMRE fluorescence
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can undergo several post-translational modifications with 
serine 129 phosphorylation being found in up to 90 % of 
the α-synuclein of Lewy bodies having this modification, 
which is linked with aggregate formation in cell models 
(Fujiwara et al. 2002; Smith et al. 2005). Of note is that 
diquat did not cause any changes in α-synuclein expression 
with no changes in protein levels or intracellular aggrega-
tion following 24 h or 4 weeks of low-dose exposure. Para-
quat has been suggested to increase α-synuclein levels in 
cells (Yang and Tiffany-Castiglioni 2007) and can also 
cause increased expression and aggregation of α-synuclein 
in vivo (Manning-Bog et al. 2002) although this is not seen 
in some studies even in the presence of dopaminergic cell 
death (Thiruchelvam et al. 2003). Diquat may, therefore, 
differ significantly in its ability to promote α-synuclein 
aggregation and consequent PD-related toxicity.
To determine a mode of cell death for diquat, pharmaco-
logical inhibition of apoptosis using caspase inhibitors was 
used. In primary dopaminergic neurons or cell lines, caspase 
inhibitors have shown protection against MPP+ toxicity, 
but such an effect could be temporary and can switch from 
apoptosis to necrosis (Choi et al. 1999). Caspase inhibi-
tors failed to reduce diquat toxicity suggesting a non-cas-
pase-directed pathway. A range of different apoptotic and 
response markers can be detected after toxin treatment, their 
absence, presence or cleavage indicating the mode of cell 
death. Poly (ADP-ribose) polymerase (PARP-1, 116 kDa) 
is a nuclear enzyme involved in DNA repair in response to 
environmental stress (Satoh and Lindahl 1992). The pres-
ence of activated PARP and p53 only at later stages of 
diquat exposure suggests that apoptosis and DNA damage 
may be only minor event associated with diquat toxicity. 
Previous studies have shown that caspase inhibition does not 
always protect against apoptosis and alternative cell death 
mechanisms may be involved (McCarthy et al. 1997; Villa 
et al. 1998). Furthermore, autophagy may be responsible 
for cell death caused by chemical insult, which can be pre-
vented by using autophagy inhibitors (Shimizu et al. 2004). 
Involvement of programmed necrosis or “necroptosis” in 
diquat toxicity is indicated (Edinger and Thompson 2004; 
Festjens et al. 2006) since use of Nec-1 which inhibits RIP1 
kinase reduces diquat toxicity (Degterev et al. 2008). RIP1 
is required for the initiation of caspase-independent necrotic 
cell death as part of a signalling complex comprised of 
TNF-R1-associated death domain protein (TRADD), small 
GTPase Rac1 and Nox1 (NADPH oxidase). RIP1 recruits 
Nox1 to the signalling complex when necrosis is initiated 
(Kim et al. 2007), and NADPH oxidase enzymes actively 
play a role in the production of ROS (Lambeth 2004). 
Although the mechanism(s) underlying the protective action 
of Nec-1 is unclear, Nec-1 appears to block formation of the 
RIP1 containing “ripoptosome”, blocking events leading 
to cell death after oxidative stress (Feoktistova et al. 2011; 
Tenev et al. 2011). Since diquat can undergo redox cycling 
generating free radicals (Sandy et al. 1986) potentially via 
microsomal reduction (Tomita 1991), one mode of action of 
diquat is to produce free radicals and activate programmed 
necrosis via RIP1. Diquat-mediated cell death is accompa-
nied by elevated DCFDA fluorescence, and also, the anti-
oxidant NAC partially prevents cell death. NAC is a free 
radical scavenger and glutathione mimetic (Martinez et al. 
1999) and also enhances glutathione synthesis suggesting 
that diquat undergoes redox cycling and increases oxidative 
stress by depleting cellular glutathione, a finding seen with 
Fig. 8  Inhibition of NADH: quinone reductase (complex I) activity. 
Complex I activity (measured as rate of change of NADH oxidised 
in μmols of NADH oxidised/min) in a untreated (DMSO; without 
rotenone addition), b rotenone (5 µM), c diquat (40 µM), d paraquat 
(40 µM), e MPP+ (40 µM) and f MPTP (100 µM). Rotenone (5 µM) 
shows rapid and almost complete inhibition of activity, whilst other 
toxins show minimal inhibition of CI activity over the time period
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MPTP where glutathione depletion potentiates MPTP tox-
icity in vivo (Wullner et al. 1996). In line with these find-
ings for diquat, paraquat which is thought to generate ROS 
through cytochrome P-450-mediated redox cycling (Suntres 
2002) also showed low levels of ROS production. Rotenone 
also showed ROS production after exposure of cells with 
our findings attributable to the known production of super-
oxide and other ROS by mitochondrial complex I inhibition 
(Molina-Jimenez et al. 2005). Oxidative damage contributes 
to dopaminergic cell death in PD with increased markers of 
oxidative stress being found in PD substantia nigra (Jenner 
1998). ROS generation following toxin exposure appears 
to occur before complete mitochondrial transmembrane 
potential (ΔΨm) dissipation, and all toxins showed a direct 
relationship between ROS generation and disruption of the 
ΔΨm. Redox cycling of diquat in the presence of NADPH 
and cytochrome P450 reductase likely causes the highly 
unstable diquat radical to transfer an electron to molecu-
lar oxygen to form a superoxide anion radical (Sandy et al. 
1986) causing widespread cellular damage and cell death.
Mitochondrial respiratory chain inhibition is a factor in 
sporadic and chemical-associated PD (Keane et al. 2011). 
Diquat (1–100 µM) failed to cause CI inhibition in this 
system despite other known CI inhibitors having an effect, 
indicating that diquat does not act through direct mitochon-
drial inhibition. Rotenone is a potent mitochondrial CI 
inhibitor causing reduction in ΔΨm, cytochrome c release 
and caspase-9 activation (Mattson 2000). In this study, 
rotenone showed a complete inhibition of CI activity and 
presence of cellular mitochondrial aggregation which cou-
pled with reduction in ΔΨm shows hallmarks of early-stage 
mitochondrial-mediated cell death (Benard et al. 2007; 
Mortiboys et al. 2008; Barsoum et al. 2006). Whilst CI 
inhibition has been shown by rotenone, recent work indi-
cates that there may be additional mechanisms which do 
not involve CI inhibition through which rotenone and also 
MPTP have their mode of action (Choi et al. 2011). MPP+ 
reduced CI activity similar to rotenone in a dose-dependent 
manner with a 40 % reduction at 100 nM after prolonged 
exposure. It is accepted that complex I inhibition remains 
the main target of MPP+ action, but alternative mecha-
nisms like reduction in ΔΨm (shown here), inhibition of 
glycolysis, microtubule depolymerisation and oxidative 
stress may also play part in MPP+ neurotoxicity (Cappel-
letti et al. 2005; Choi et al. 2008). Unlike previous studies 
(Fukushima et al. 1994), inhibition of CI activity of isolated 
mitochondria in vitro was not seen in this study for para-
quat, and the suggestion that it shows functional similarity 
with MPP+ has been questioned previously (Richardson 
et al. 2005). Whilst paraquat is actively transported through 
isolated mitochondrial membranes and reduced to a radi-
cal cation by CI (Cocheme and Murphy 2008), its ability 
to reach the internal mitochondrial membrane and inhibit 
complex I in intact cells is unclear (Shimada et al. 1998). 
Our data suggest that paraquat does not act as a CI or CII 
inhibitor, or inhibit the ΔΨm (not shown), agreeing with 
the suggestion that paraquat causes oxidative stress inde-
pendent of CI inhibition (McCormack et al. 2005, 2006).
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Fig. 9  Mean CI and CII activities in MPP+ treated SH-SY5Y mito-
chondria. Complex I (μmols of NADH oxidised/min) and complex II 
(nmols DCPIP reduced/min) activity after 1-h incubation with MPP+ 
(10 and 100 nM) and diquat (1, 10 and 100 µM) (n = 3, ±SD). The 
effects of toxins were determined on isolated mitochondria with rote-
none (5 µM) used as the internal control to define complex I activity. 
MPP+ showed a significant effect on complex I after 1 h (P < 0.05), 
whilst diquat (DQ) showed no significant effect on activity after 1-h 
incubation. No toxin showed a significant effect on CII activity
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In summary, diquat causes a caspase-independent cell 
death, potentially resembling programmed necrosis, by 
increasing ROS, most likely by direct oxidative cycling and 
independently of mitochondria. Exposure to diquat in vivo 
whilst being toxic and causing CNS damage may not nec-
essarily cause dopaminergic neurones to show increased 
susceptibility to other cell stresses, leading to cell death 
and the clinical symptoms of PD. A significant finding here 
is that even at the relatively high doses achieved in vitro 
which are unlikely to be achieved in vivo, diquat did not 
induce changes in α-synuclein or give any major changes 
in mitochondrial activity, two significant features of the 
majority of idiopathic Lewy body PD. If diquat does play 
a role in PD, it may only play a role in the rarer forms of 
parkinsonism where Lewy bodies do not appear to be a 
feature.
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